Be Biopharma
PrivateLast Round
Series C
Jan 15, 2025
Total Funding Raised
$356M
Company Overview
Be Biopharma is a biotechnology company that develops engineered B cell medicines to treat genetic diseases, cancer, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Be Biopharma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Be Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 15, 2025 | ||||
| Early Funding | Oct 22, 2024 | ||||
| Series B | Apr 14, 2022 | ||||
| Series A | Oct 23, 2020 |
Key People
Founding team and executive leadership
Be Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B, Series C, Early Funding, Series A |
| Dean Capital Investments Management | Series B |
| ARCH Venture Partners | Series C, Series B |
| ARCH Venture Partners | Series C, Early Funding, Series B |
| Nextech Venture | Series C |
| Alta Administration | Series B |
| Atlas Venture | Series B, Series C, Early Funding, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2025
Therapeutic programs have advanced into human trials.
- Jan 15, 2025
$92M round completed.
Be Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Be Biopharma's valuation, stock price, and market status.